Cargando…

Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient

A 21 year old MSM patient with newly diagnosed HIV infection was hospitalized in our department after ingestion of an overdose of his antiretroviral therapy (ART) comprising dolutegravir (DTG - Tivicay®) and tenofovir disaproxil fumarate/emtricitabine (Truvada®) in suicidal intention. On admission,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Marcel, Eyer, Florian, Felgenhauer, Norbert, Klinker, Hartwig HF, Spinner, Christoph D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455705/
https://www.ncbi.nlm.nih.gov/pubmed/26045712
http://dx.doi.org/10.1186/s12981-015-0054-y
_version_ 1782374766037958656
author Lee, Marcel
Eyer, Florian
Felgenhauer, Norbert
Klinker, Hartwig HF
Spinner, Christoph D
author_facet Lee, Marcel
Eyer, Florian
Felgenhauer, Norbert
Klinker, Hartwig HF
Spinner, Christoph D
author_sort Lee, Marcel
collection PubMed
description A 21 year old MSM patient with newly diagnosed HIV infection was hospitalized in our department after ingestion of an overdose of his antiretroviral therapy (ART) comprising dolutegravir (DTG - Tivicay®) and tenofovir disaproxil fumarate/emtricitabine (Truvada®) in suicidal intention. On admission, the patient did not show any clinical signs of intoxication and laboratory findings were unremarkable. After 6 hours of intensive care monitoring, the patient was referred to a psychiatric clinic. 5 days after the day of intoxication, serum creatinine levels increased to high normal values (1.2 mg/dl). However, levels never exceeded the upper threshold. 8 and 12 weeks later, serum creatinine normalized to levels measured prior to the intoxication. No other adverse events occurred, and the patient does not suffer from permanent impairments.
format Online
Article
Text
id pubmed-4455705
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44557052015-06-05 Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient Lee, Marcel Eyer, Florian Felgenhauer, Norbert Klinker, Hartwig HF Spinner, Christoph D AIDS Res Ther Case Report A 21 year old MSM patient with newly diagnosed HIV infection was hospitalized in our department after ingestion of an overdose of his antiretroviral therapy (ART) comprising dolutegravir (DTG - Tivicay®) and tenofovir disaproxil fumarate/emtricitabine (Truvada®) in suicidal intention. On admission, the patient did not show any clinical signs of intoxication and laboratory findings were unremarkable. After 6 hours of intensive care monitoring, the patient was referred to a psychiatric clinic. 5 days after the day of intoxication, serum creatinine levels increased to high normal values (1.2 mg/dl). However, levels never exceeded the upper threshold. 8 and 12 weeks later, serum creatinine normalized to levels measured prior to the intoxication. No other adverse events occurred, and the patient does not suffer from permanent impairments. BioMed Central 2015-05-21 /pmc/articles/PMC4455705/ /pubmed/26045712 http://dx.doi.org/10.1186/s12981-015-0054-y Text en © Lee et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Lee, Marcel
Eyer, Florian
Felgenhauer, Norbert
Klinker, Hartwig HF
Spinner, Christoph D
Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
title Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
title_full Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
title_fullStr Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
title_full_unstemmed Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
title_short Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
title_sort overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455705/
https://www.ncbi.nlm.nih.gov/pubmed/26045712
http://dx.doi.org/10.1186/s12981-015-0054-y
work_keys_str_mv AT leemarcel overdoseofdolutegravirincombinationwithtenofovirdisaproxilfumarateemtricitabineinsuicideattemptina21yearoldpatient
AT eyerflorian overdoseofdolutegravirincombinationwithtenofovirdisaproxilfumarateemtricitabineinsuicideattemptina21yearoldpatient
AT felgenhauernorbert overdoseofdolutegravirincombinationwithtenofovirdisaproxilfumarateemtricitabineinsuicideattemptina21yearoldpatient
AT klinkerhartwighf overdoseofdolutegravirincombinationwithtenofovirdisaproxilfumarateemtricitabineinsuicideattemptina21yearoldpatient
AT spinnerchristophd overdoseofdolutegravirincombinationwithtenofovirdisaproxilfumarateemtricitabineinsuicideattemptina21yearoldpatient